Quadrant Capital Group’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,550
| Closed | -$24.2K | – | 1418 |
|
|
2025
Q1 | $24.2K | Hold |
1,550
| – | – | ﹤0.01% | 1982 |
|
|
2024
Q4 | $21.6K | Hold |
1,550
| – | – | ﹤0.01% | 1856 |
|
|
2024
Q3 | $14.4K | Hold |
1,550
| – | – | ﹤0.01% | 2029 |
|
|
2024
Q2 | $14.4K | Sell |
1,550
-326
| -17% | -$3.03K | ﹤0.01% | 1988 |
|
|
2024
Q1 | $18.6K | Buy |
+1,876
| New | +$18.6K | ﹤0.01% | 1878 |
|
|
2023
Q4 | – | Sell |
-936
| Closed | -$4.97K | – | 2698 |
|
|
2023
Q3 | $4.97K | Buy |
936
+875
| +1,434% | +$4.65K | ﹤0.01% | 2177 |
|
|
2023
Q2 | $582 | Buy |
+61
| New | +$582 | ﹤0.01% | 2554 |
|